Stimulation of lysosomal sphingomyelin degradation by sphingolipid activator proteins

Chemistry and Physics of Lipids

Volumn 102, Issue 1-2, 1999, Pages 35-43

  Ferlinz, Klaus ^a   Linke, Thomas ^a   Bartelsen, Oliver ^a   Weiler, Manfred ^a   Sandhoff, Konrad ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Acid sphingomyelinase; Intra lysosomal vesicles; Sphingolipid activator proteins

Indexed keywords

GLYCOSPHINGOLIPID; SPHINGOLIPID; SPHINGOLIPID ACTIVATOR PROTEIN; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ARTICLE; HUMAN; HYDROLYSIS; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; CARBOHYDRATE SEQUENCE; GLYCOPROTEINS; HUMANS; LYSOSOMES; MOLECULAR SEQUENCE DATA; SAPOSINS; SPHINGOLIPID ACTIVATOR PROTEINS; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS;

EID: 0032869317     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(99)00073-0     Document Type: Article

References (33)

1. Bartelsen, O., Lansmann, S., Nettersheim, M., Lemm, T., Ferlinz, K., Sandhoff, K., 1998. Expression of recombinant human acid sphingomyelinase in insect Sf 21 cells: purification, processing and enzymatic characterization. J. Biotech. 163, 29-40.
2. Bradovà V., Smìd F., Ulrich-Bott B., Roggendorf W., Paton B.C., Harzer K. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease. Hum. Genet. 92:1993;143-152.
3. Christomanou H., Kleinschmidt T. Isolation of two forms of an activator protein for the enzymic sphingomyelin degradation from human Gaucher spleen. Biol. Chem. Hoppe Seyler. 366:1985;245-256.
4. Christomanou H., Aignesberger A., Linke R.P. Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant. Biol. Chem. Hoppe Seyler. 367:1986;879-890.
5. Fujita N., Suzuki K., Vanier M.T., Popko B., Macda N., Klein A., Henseler M., Sandhoff K., Nakayasu H., Suzuki K. Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids. Hum. Mol. Genet. 5:1996;711-725.
6. Fürst W., Sandhoff K. Activator proteins and topology of lysosomal sphingolipid catabolism. Biochim. Biophys. Acta. 1126:1992;1-16.
7. Giehl, A., Lemm, T., Bartelsen, O., Sandhoff, K., Blume, A., 1998. Interaction of the GM2-activator protein with phospholipid/ganglioside model membranes and adsorption at the air/water interface. Eur. J. Biochem. 261, 650-658.
8. Gieselmann V. lysosomal storage diseases. Biochim. Biophys. Acta. 1270:1995;103-136.
9. Hakomori S., Igarashi Y. Functional role of glycosphingolipids in cell recognition and signaling. J. Biochem. 118:1995;1091-1103.
10. Hannun Y.A., Obeid L.M. Mechanisms of ceramide-mediated apoptosis. Adv. Exp. Med. Biol. 407:1997;145-149.
11. Harzer K., Paton B.C., Poulos A., Kustermann-Kuhn B., Roggendorf W., Griser T., Popp M. Sphingolipid activator protein deficiency in a 16-week old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses. Eur. J. Pediatr. 149:1989;31-39.
12. Hiesberger, T., Hüttler, S., Rohlmann, A., Schneider, W., Sandhoff, K., Herz, J., 1998. Cellular uptake of saposine (SAP) precursor and lysosomal delivery by the low density lipoprotein receptor-related protein (LRP). EMBO J. 16, 1417-4625.
13. Ida H., Rennert O.M., Eto Y., Chan W.-Y. Cloning of a human acid sphingomyelinase cDNA with a new mutation that renders the enzyme inactive. J. Biochem. 114:1993;15-20.
14. Kobayashi T., Stang E., Fang K.S., de Moerloose P., Parton R.G., Gruenberg J. A lipid associated with the antiphospholipid syndrome regulates the endosome structure and function. Nature. 392:1998;193-197.
15. Kolter T., Sandhoff K. Biochemistry of sphingolipid degradation. Clin. Chim. Acta. 266:1997;51-61.
16. Lansmann S., Ferlinz K., Hurwitz R., Glombiza G., Sandhoff K. Purification, characterization and N-terminal sequencing of homogenous acid sphingomyelinase from human placenta. FEBS Lett. 399:1996;227-231.
17. Linke, T., Wilkening, G., Moczall, H., Lansmann, S., Bartelsen, O., Sandhoff, K., 1999. Influence of lysosomal components on sphingomyelin hydrolysis in a detergent-free system (in preparation).
18. Liu Y., Hoffmann A., Grinberg A., Westphal H., McDonald M.P., Miller K.M., Crawley J.N., Sandhoff K., Suzuki K., Proia R.L. Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment. Proc. Natl. Acad. Sci. USA. 94:1997;8138-8143.
19. Morimoto S., Martin M., Kishimoto Y., O'Brien J.S. Saposin D: a sphingomyelinase activator. Biochem. Biophys. Res. Commun. 156:1988;503-510.
20. Munford R.S., Sheppard P.O., O'Hara P.J. Saposin-like proteins (SAPLIP) carry out diverse functions on a common backbone structure. J. Lipid Res. 36:1995;1653-1663.
21. Paton B.C., Hughes J.L., Harzer K., Poulos A. Immunocytochemical localization of sphingolipid activator protein 2 (SAP-2) in normal and SAP-deficient fibroblasts. Eur. J. Cell Biol. 51:1990;157-164.
22. Paton B.C., Schmid B., Kustermann-Kuhn B., Poulos A., Harzer K. Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Biochem. J. 285:1992;481-488.
23. Ponting C.P. Acid sphingomyelinase possesses a domain homologous to its activator proteins B and D. Protein Sci. 3:1994;359-361.
24. Poulos A., Ranieri E., Shankaran P., Callahan J.W. Studies on the activation of the enzymatic hydrolysis of sphingomyelin liposomes. Biochem. Biophys. Acta. 793:1984;141-148.
25. Quintern L.E., Schuchman E.H., Levran O., Suchi M., Ferlinz K., Reinke H., Sandhoff K., Desnick R.J. Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts. EMBO J. 8:1989;2469-2473.
26. Sandhoff K., Harzer K., Fürst W. Scriver C., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Disease. 1995;2427-2441 McGraw Hill, New York.
27. Sano A., Radin N.S., Johnson L.L., Tarr G.E. The activator protein for glucosylceramide beta-glucosidase from guinea pig liver. Improved isolation method-and complete amino acid sequence. J. Biol. Chem. 263:1988;19597-19601.
28. Schnabel D., Schröder M., Fürst W., Klein A., Hurwitz R., Zenk T., Weber J., Harzer K., Paton B.C., Suzuki K., Sandhoff K. Simultaneous deficiency of sphingolipid activator proteins 1 and 2 is caused by a mutation in the initiation codon of their common gene. Biol. Chem. 267:1992;3312-3315.
29. Schuchman E.H., Desnick R.J. Niemann-Pick disease types A and B: acid sphingomyelinase deficiencies. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Bases of Inherited Disease. 7th edn:1995;2601-2624 McGraw Hill, New York.
30. Spiegel S., Foster D., Kolesnick R. Signal transduction through lipid second messengers. Curr. Opin. Cell Biol. 8:1996;159-168.
31. Tayama M., Soeda S., Kishimoto Y., Martin B., Callahan J.W., Hiraiwa M., O'Brien J.S. Effect of saposins on acid sphingomyelinase. Biochem. J. 290:1993;401-404.
32. Vielhaber G., Hurwitz R., Sandhoff K. Biosynthesis, processing and targeting of SAP precursor in cultured human fibroblasts: mannose-6-phosphate receptor independent endocytosis of SAP-precursor. J. Biol. Chem. 271:1996;32438-32446.
33. Wilkening, G., Linke, T., Sandhoff, K., 1999. Lysosomal degradation on vesicular membrane surfaces: Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators. J. Biol. Chem. 273, 30271-30278.